Mirna Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

Mirna Therapeutics General Information

Description

Developer of micro ribonucleic acid (miRNA) based oncology therapeutics. The company's miRNA drug kills cancer cells by regaining control over multiple oncogenic pathways.

Contact Information

Website
www.mirnarx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • PO Box 163387
  • Austin, TX 78716
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • PO Box 163387
  • Austin, TX 78716
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirna Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 28-Aug-2017 Completed Generating Revenue
10. IPO 30-Sep-2015 Completed Clinical Trials - Phase 1
9. Later Stage VC (Series D) 30-Mar-2015 Completed Clinical Trials - Phase 1
8. Grant 22-May-2014 Completed Pre-Clinical Trials
7. Later Stage VC (Series C) 24-Oct-2012 Completed Pre-Clinical Trials
6. Early Stage VC (Series B1) Completed Product Development
5. Early Stage VC (Series B) 23-Aug-2011 Completed Product Development
4. Grant 01-Jan-2010 Completed Product Development
3. Grant 01-Jan-2009 $5M $8M Completed Product Development
2. Early Stage VC (Series A) 01-Jan-2009 $5M $8M Completed Product Development
To view Mirna Therapeutics’s complete valuation and funding history, request access »

Mirna Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B1
Series B 540,341 $0.001000 $2.78 $2.11 0x $2.78 0.31%
Series A 3,192,083 $0.001000 $2 $1.33 0x $2 1.82%
To view Mirna Therapeutics’s complete cap table history, request access »

Mirna Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of micro ribonucleic acid (miRNA) based oncology therapeutics. The company's miRNA drug kills cancer cells by
Biotechnology
Austin, TX
16 As of 2015

Brisbane, CA
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mirna Therapeutics Competitors (79)

One of Mirna Therapeutics’s 79 competitors is Vera Therapeutics, a Formerly VC-backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vera Therapeutics Formerly VC-backed Brisbane, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
Corvus Pharmaceuticals Formerly VC-backed South San Francisco, CA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Corbus Pharmaceuticals Holdings Formerly VC-backed Norwood, MA
You’re viewing 5 of 79 competitors. Get the full list »

Mirna Therapeutics Patents

Mirna Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140378528-A1 Biomarkers of mir-34 activity Inactive 24-Jun-2013

Mirna Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mirna Therapeutics Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asuragen Corporation Minority
Baxalta Corporation Minority
Baxter Ventures Corporate Venture Capital Minority
Cancer Prevention and Research Institute of Texas Government Minority
Celgene Corporation Minority
You’re viewing 5 of 18 investors. Get the full list »

Mirna Therapeutics Acquisitions (1)

Mirna Therapeutics’s most recent deal was a Reverse Merger with Synlogic. The deal was made on 28-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Synlogic 28-Aug-2017 Reverse Merger Drug Discovery
To view Mirna Therapeutics’s complete acquisitions history, request access »

Mirna Therapeutics FAQs

  • When was Mirna Therapeutics founded?

    Mirna Therapeutics was founded in 2007.

  • Where is Mirna Therapeutics headquartered?

    Mirna Therapeutics is headquartered in Austin, TX.

  • What is the size of Mirna Therapeutics?

    Mirna Therapeutics has 16 total employees.

  • What industry is Mirna Therapeutics in?

    Mirna Therapeutics’s primary industry is Biotechnology.

  • Is Mirna Therapeutics a private or public company?

    Mirna Therapeutics is a Private company.

  • What is Mirna Therapeutics’s current revenue?

    The current revenue for Mirna Therapeutics is .

  • How much funding has Mirna Therapeutics raised over time?

    Mirna Therapeutics has raised $141M.

  • Who are Mirna Therapeutics’s investors?

    Asuragen, Baxalta, Baxter Ventures, Cancer Prevention and Research Institute of Texas, and Celgene are 5 of 18 investors who have invested in Mirna Therapeutics.

  • Who are Mirna Therapeutics’s competitors?

    Vera Therapeutics, Kite Pharma, Corvus Pharmaceuticals, Intellia Therapeutics, and Corbus Pharmaceuticals Holdings are some of the 79 competitors of Mirna Therapeutics.

  • When was Mirna Therapeutics acquired?

    Mirna Therapeutics was acquired on 28-Aug-2017.

  • Who acquired Mirna Therapeutics?

    Mirna Therapeutics was acquired by Synlogic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process